← All trials
NCT03719105
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2019
- Primary completion
- Dec 31, 2022
- Completion date
- Dec 31, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- New York Medical CollegeLead sponsor
- New York Medical CollegeStudy director
- New York Medical CollegeReponsible party - principal investigator
- University of Alabama, BirminghamCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.